Regenicin, Inc. Proceeds from Stock Options Exercised
Regenicin, Inc. reported Proceeds from Stock Options Exercised of $1.50 thousand for the 12-month period ending 2015-09-30, per its 10-K filed 2017-01-17.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2017-01-17
- Regenicin, Inc. proceeds from stock options exercised for fiscal 2015 was $1.50K.
| Period end | Proceeds from Stock Options Exercised 12 month |
|---|---|
| 2015-09-30 | $1.50K 10-K · filed 2017-01-17 |